Acute liver failure: targeted artificial and hepatocyte-based support of liver regeneration and reversal of multiorgan failure.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Hepatology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0168-8278(00)80416-XPMID 10728795
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of a bioartificial liver with sandwiched-cultured hepatocytes between two collagen gel layers.

  2008cited by this paper
• Artificial liver: the effect of ACAC microencapsulated charcoal hemoperfusion on fulminant hepatic failure.

  2008cited by this paper
• Principles of therapeutic liver repopulation

  2006cited by this paper
• UvA-DARE ( Digital Academic Repository ) In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates

  2001cited by this paper
• An experimental artificial liver utilizing extracorporeal metabolism with sliced or granulated canine liver.

  2000cited by this paper
• Fulminant hepatic failure.

  2000cited by this paper
• Temporary Extracorporeal Liver Support for Severe Acute Alcoholic Hepatitis Using the Biologic-DT

  1999cited by this paper
• Plasma cytokine levels and coagulation and complement activation during use of the extracorporeal liver assist device in acute liver failure.

  1998cited by this paper
• Temporary Extracorporeal Liver Support for Severe Acute Alcoholic Hepatitis Using the Biologic-Dt

  1998cited by this paper
• Impaired liver regeneration in inducible nitric oxide synthasedeficient mice.

  1998cited by this paper
• A comparison between the Fick method and indirect calorimetry for determining oxygen consumption in patients with fulminant hepatic failure.

  1998cited by this paper
• The effect of N‐acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure

  1998cited by this paper
• In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model.

  1998cited by this paper
• Signal transduction during liver regeneration

  1998cited by this paper
• Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure.

  1998cited by this paper
• The beneficial effects of ciprofloxacin on survival and hepatic regenerative activity in a rat model of fulminant hepatic failure

  1998cited by this paper
• A functional model of hepatocyte transplantation for in vivo immunologic studies.

  1998cited by this paper
• Evidence for altered central noradrenergic function in experimental acute liver failure in the rat

  1998cited by this paper
• Experimental hepatectomy: the effect on the intestine and influence of various supplements.

  1997cited by this paper
• Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure.

  1997cited by this paper
• Binding of the Transcription Factor Interferon Regulatory Factor-1 to the Inducible Nitric-oxide Synthase Promoter*

  1997cited by this paper
• Loss and recovery of liver regeneration in rats with fulminant hepatic failure.

  1997cited by this paper
• In vivo evaluation of a novel bioartificial liver in a surgical model of acute liver failure in the pig: preliminary results

  1997cited by this paper
• Plasma levels and hepatic mRNA expression of transforming growth factor-β1 in patients with fulminant hepatic failure

  1997cited by this paper
• Treatment of surgically induced acute liver failure by transplantation of conditionally immortalized hepatocytes.

  1997cited by this paper
• Split liver/auxiliary liver transplantation for fulminant hepatic failure.

  1997cited by this paper
• Nonparenchymal cells from regenerating rat liver generate interleukin‐1α and ‐1β: A mechanism of negative regulation of hepatocyte proliferation

  1997cited by this paper
• Contrasting effects of identical nutrients given parenterally or enterally after 70% hepatectomy: bacterial translocation.

  1997cited by this paper
• Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor.

  1997cited by this paper
• Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial.

  1997cited by this paper
• Infection of human cells by an endogenous retrovirus of pigs

  1997cited by this paper
• Plasma levels and hepatic mRNA expression of transforming growth factor-beta1 in patients with fulminant hepatic failure.

  1997cited by this paper
• Nonparenchymal cells from regenerating rat liver generate interleukin-1alpha and -1beta: a mechanism of negative regulation of hepatocyte proliferation.

  1997cited by this paper
• Nitric Oxide Inhibits Apoptosis by Preventing Increases in Caspase-3-like Activity via Two Distinct Mechanisms*

  1997cited by this paper
• Xenoantibody response of patients with severe acute liver failure exposed to porcine antigens following treatment with a bioartificial liver.

  1997cited by this paper
• Liver function, cerebral blood flow autoregulation, and hepatic encephalopathy in fulminant hepatic failure

  1997cited by this paper
• Continuous HGF supply from HGF-expressing fibroblasts transplanted into spleen prevents CCl4-induced acute liver injury in rats.

  1996cited by this paper
• A Carrier-Mediated Transport of Toxins in a Hybrid Membrane. Safety Barrier between a Patients Blood and a Bioartificial Liver

  1996cited by this paper
• Influence of alginate gel entrapment and cryopreservation on survival and xenobiotic metabolism capacity of rat hepatocytes.

  1996cited by this paper
• Use of Bioartificial and Artificial Liver Support Devices

  1996cited by this paper
• Treatment of acute liver failure by high volume plasmapheresis

  1996cited by this paper
• Acute Liver Failure: Dialysis/adsorption techniques for acute liver failure

  1996cited by this paper
• Cryopreservation of porcine hepatocyte cultures.

  1996cited by this paper
• Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium

  1996cited by this paper
• Pilot‐controlled trial of the extracorporeal liver assist device in acute liver failure

  1996cited by this paper
• Transplantation of conditionally immortalized hepatocytes to treat hepatic encephalopathy

  1996cited by this paper
• Mass Transfer Limitations to the Performance of Membrane Bioartificial Liver Support Devices

  1996cited by this paper
• Acute Liver Failure: Hepatocyte replication and liver regeneration

  1996cited by this paper
• Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice

  1996cited by this paper
• Human liver cell lines proliferative freely and maintain their differentiated phenotype secreting high levels of liver specific proteins when grown in 3-dimensional culture for over 20 days.

  1996cited by this paper
• In vivo footprinting of the mouse inducible nitric oxide synthase gene: inducible protein occupation of numerous sites including Oct and NF-IL6.

  1996cited by this paper
• Cell strains derived from normal human hepatocytes by infection with a retrovirus containing the SV40 large-T-antigen.

  1996cited by this paper
• Evidence of increased guanylate cyclase activation by acetylcysteine in fulminant hepatic failure

  1996cited by this paper
• Cell Sources for Bioartificial Liver Support

  1996cited by this paper
• Neuroactive amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure

  1996cited by this paper
• Acute Liver Failure: Management of infection in acute liver failure

  1996cited by this paper
• Unifying theory of hypoxia tolerance: molecular/metabolic defense and rescue mechanisms for surviving oxygen lack.

  1996cited by this paper
• Induction of rat liver parenchymal cell apoptosis by hepatic myofibroblasts via transforming growth factor β

  1996cited by this paper
• Fulminant hepatic failure in rats: Survival and effect on blood chemistry and liver regeneration

  1996cited by this paper
• Establishment of a human hepatocyte line derived from primary culture in a collagen gel sandwich culture system.

  1995cited by this paper
• A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993).

  1995cited by this paper
• Improved hepatocyte in vitro maintenance in a culture model with woven multicompartment capillary systems: Electron microscopy studies

  1995cited by this paper
• Immediate early detection of urokinase receptor after partial hepatectomy and its implications for initiation of liver regeneration

  1995cited by this paper
• Epidermal growth factor secreted from the salivary gland is necessary for liver regeneration.

  1995cited by this paper
• A novel bioreactor design for in vitro reconstruction of in vivo liver characteristics.

  1995cited by this paper
• Interleukin‐1 and nitric oxide protect against tumor necrosis factor α‐induced liver injury through distinct pathways

  1995cited by this paper
• Concentrations of 3,4‐Dihydroxyphenylalanine and Catecholamines and Metabolites in Brain in an Anhepatic Model of Hepatic Encephalopathy

  1995cited by this paper
• Liver cell necrosis: cellular mechanisms and clinical implications.

  1995cited by this paper
• Endotoxin and interleukin‐1 related hepatic inflammatory response promotes liver failure after partial hepatectomy

  1995cited by this paper
• Tolerance against tumor necrosis factor alpha (TNF)-induced hepatotoxicity in mice: the role of nitric oxide.

  1995cited by this paper
• Ciprofloxacin prevents the inhibitory effects of acute ethanol exposure on hepatic regeneration in the rat

  1995cited by this paper
• Regulation of hepatic genes and liver transcription factors in rat hepatocytes by extracellular matrix.

  1995cited by this paper
• The effects of hyperperfusion in the isolated perfused rat liver

  1995cited by this paper
• Cerebral blood flow and metabolism in fulminant liver failure

  1994cited by this paper
• Humoral inhibitor of rat hepatocyte DNA synthesis from patients with fulminant liver failure

  1994cited by this paper
• Hepatocyte Culture between Three Dimensionally Arranged Biomatrix-Coated Independent Artificial Capillary Systems and Sinusoidal Endothelial Cell Co-Culture Compartments

  1994cited by this paper
• Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver.

  1994cited by this paper
• Human fetal hepatocyte transplantation in patients with fulminant hepatic failure.

  1994cited by this paper
• Metabolic Abnormalities and Grade of Encephalopathy in Acute Hepatic Failure

  1994cited by this paper
• Plasma hepatocyte growth factor and biliprotein levels and outcome in fulminant hepatic failure.

  1994cited by this paper
• Characterization of human hepatocyte lines derived from normal liver tissue

  1994cited by this paper
• The Hepatix extracorporeal liver assist device: initial clinical experience.

  1994cited by this paper
• Cell-extracellular matrix interactions can regulate the switch between growth and differentiation in rat hepatocytes: reciprocal expression of C/EBP alpha and immediate-early growth response transcription factors

  1994cited by this paper
• Evaluation of the BioLogic-DT sorbent-suspension dialyser in patients with fulminant hepatic failure

  1994cited by this paper
• Acute liver failure: redefining the syndromes.

  1993cited by this paper
• Optimization of hepatocyte attachment to microcarriers: Importance of oxygen

  1993cited by this paper
• Activation of the fibrinolytic system in patients with fulminant liver failure

  1993cited by this paper
• Cell-matrix interactions in liver.

  1993cited by this paper
• Alteration of transcription factor mRNAs during the isolation and culture of rat hepatocytes suggests the activation of a proliferative mode underlies their de-differentiation.

  1993cited by this paper
• Transforming growth factor beta gene expression is transiently enhanced at a critical stage during liver regeneration after CCl4 treatment.

  1993cited by this paper
• Anoxic suppression of Na(+)-K(+)-ATPase and constant membrane potential in hepatocytes: support for channel arrest.

  1993cited by this paper
• Liver stem cells

  1993cited by this paper
• A new procedure for the removal of protein bound drugs and toxins.

  1993cited by this paper
• Defective cerebrovascular autoregulation after carotid endarterectomy.

  1993cited by this paper
• Classification of acute liver failure

  1993cited by this paper
• Cell-specific expression of hepatocyte growth factor in liver. Upregulation in sinusoidal endothelial cells after carbon tetrachloride.

  1993cited by this paper
• Reduction of cerebral perfusion precedes rise of intracranial pressure in rats with ischemic fulminant liver failure

  1993cited by this paper
• Statistics: the glitter of the t table

  1993cited by this paper
• Immunologic considerations in the use of cultured porcine hepatocytes as a hybrid artificial liver. Anti-porcine hepatocyte human serum.

  1993cited by this paper
• Artificial Liver Support

  1992cited by this paper

• Selectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 as a rapid-acting therapy for advanced acute liver failure

  2024cites this paper
• Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review

  2022cites this paper
• GPR120 induces regulatory dendritic cells by inhibiting HK2-dependent glycolysis to alleviate fulminant hepatic failure

  2021cites this paper
• Fabrication and in vitro evaluation of a packed-bed bioreactor based on galactosylated poly(ethylene terephthalate) microfibrous scaffolds

  2020cites this paper
• Hepatocyte and mesenchymal stem cell co-transplantation in rats with acute liver failure

  2020cites this paper
• Sertoli cells for cell transplantation: pre‐clinical studies and future perspectives

  2018cites this paper
• The Concept of Artificial Liver Support by Using the Extracorporeal Circulation System

  2015cites this paper
• Nuclear transcription factor-kappa beta-dependent ultrastructural alterations within the placenta and systemic inflammatory activation in pregnant patients with hemolysis, elevated liver functions and low thrombocyte count (HELLP) syndrome: a case–control study

  2013cites this paper
• The role of intracellular high-mobility group box 1 in the early activation of Kupffer cells and the development of Con A-induced acute liver failure.

  2013cites this paper
• Simulation techniques with a prosthetic approach towards biologically active artificial internal organs: an overview

  2012cites this paper
• The evolving story of macrophages in acute liver failure.

  2012cites this paper
• Dynamic tracking of stem cells in an acute liver failure model.

  2012cites this paper
• Epidemiological and clinical features of hepatitis B virus related liver failure in China.

  2011cites this paper
• Factors Associated With Increased Serum Alanine Aminotransferase Levels During the French Guiana Dengue Epidemic of 2005-2006

  2010cites this paper
• Mixed microencapsulation of rat primary hepatocytes and Sertoli cells improves the metabolic function in a D-galactosamine and lipopolysaccharide-induced rat model of acute liver failure.

  2009cites this paper
• Liver cell transplantation in children

  2009cites this paper
• Effects of bone marrow and hepatocyte transplantation on liver injury.

  2009cites this paper
• The use of stem cells in liver disease

  2009cites this paper
• Development of Control System for Assisted Circulation Apparatus of Artificial Liver Support System

  2009influential citation
• Protein and cell therapy for lecithin-cholesterol acyltransferase (LCAT) deficiency

  2009cites this paper
• Refractory response to growth factors impairs liver regeneration after hepatectomy in patients with viral hepatitis.

  2009cites this paper
• An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure.

  2009cites this paper
• Clinical significance of serum HGF and c-Met expression in tumor tissue for evaluation of properties and treatment of hepatocellular carcinoma.

  2008cites this paper
• Liver transplantation for fulminant hepatic failure

  2008cites this paper
• Comparison scoring model of severe viral hepatitis and model of end stage liver disease for the prognosis of patients with liver failure in China.

  2007cites this paper
• [Animal models of fulminant hepatic failure].

  2007cites this paper
• Liver Transplantation in Children and Segmental Transplantation

  2007cites this paper
• Early renal replacement therapy in patients with postoperative acute liver failure associated with acute renal failure: effect on postoperative outcomes.

  2007cites this paper
• Continuously Microscopically Observed and Process-Controlled Cell Culture Within the SlideReactor: Proof of a New Concept for Cell Characterization

  2007cites this paper
• New Management Options for End-Stage Chronic Liver Disease and Acute Liver Failure

  2006cites this paper
• Improved Hepatocyte Excretory Function by Immediate Presentation of Polarity Cues

  2006cites this paper
• The elusive goal of liver support--quest for the Holy Grail.

  2006cites this paper
• THIS ARTICLE HAS BEEN RETRACTED: An Australian Experience With the Molecular Adsorbents Recirculating System (MARS)

  2006cites this paper
• Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child.

  2006cites this paper
• Combined human growth hormone and lactulose for prevention and treatment of multiple organ dysfunction in patients with severe chronic hepatitis B.

  2005cites this paper
• The molecular adsorbent recirculating system (MARS

  2005cites this paper
• Mathematical Model of Binding of Albumin—Bilirubin Complex to the Surface of Carbon Pyropolymer

  2005cites this paper
• Amelioration of microcirculatory damage by an endothelin A receptor antagonist in a rat model of reversible acute liver failure.

  2005cites this paper
• Co‐transplantation of encapsulated HepG2 and rat Sertoli cells improves outcome in a thioacetamide induced rat model of acute hepatic failure

  2005cites this paper
• Selected Commentary to: "Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study"

  2005cites this paper
• Acute liver failure: from bench to bedside.

  2005cites this paper
• Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study

  2005cites this paper
• Expression of growth factors in colorectal carcinoma liver metastatic patients after partial hepatectomy: implications for a functional role in cell proliferation during liver regeneration

  2004cites this paper
• PROSPECTS FOR EXTRACORPOREAL LIVER SUPPORT

  2004cites this paper
• Pathogenic molecular mechanisms in an animal model of fulminant hepatic failure: rabbit hemorrhagic viral disease.

  2004cites this paper
• Equipment review: The molecular adsorbents recirculating system (MARS®)

  2004cites this paper
• In vitro comparison of the molecular adsorbent recirculation system (MARS) and single‐pass albumin dialysis (SPAD)

  2004cites this paper
• Evaluation of effect of hybrid bioartificial liver using end-stage liver disease model.

  2004cites this paper
• Short-term survival advantage after plasma exchange in the treatment of acute on chronic liver failure or acute liver failure

  2004cites this paper
• Review Equipment review: The molecular adsorbents recirculating

  2004cites this paper
• Studies into the isolation and cryopreservation of human and porcine hepatocytes and their suitability for use in bioartificial liver development

  2004cites this paper
• Box 1 Goals of therapy with liver support devices Primary goal c In acute liver failure : recovery of patient to normal health c In acute on chronic liver failure : recovery to the state before decompensation

  2004cites this paper
• RECENT ADVANCES IN CLINICAL PRACTICE PROSPECTS FOR EXTRACORPOREAL LIVER SUPPORT

  2004cites this paper
• Acute Liver Failure: Early Referral is the Key

  2004cites this paper
• [State of hepatocyte transplantation: a risk or a chance?].

  2003cites this paper
• Extracorporeal albumin dialysis in patients with Amanita phalloides poisoning

  2003cites this paper
• Fulminant hepatic failure

  2003cites this paper
• Hepatic stimulator substance administration ameliorates liver regeneration in an animal model of fulminant hepatic failure and encephalopathy

  2003cites this paper
• [Fulminant hepatitis B].

  2003cites this paper
• Artificial Liver Support in the Third Millennium

  2003cites this paper
• Rabbit hemorrhagic viral disease: characterization of a new animal model of fulminant liver failure.

  2003cites this paper
• Granulocyte-Colony Stimulating Factor Administration Ameliorates Liver Regeneration in Animal Model of Fulminant Hepatic Failure and Encephalopathy

  2003cites this paper
• [New devices in liver replacement therapy].

  2003cites this paper
• Neue Verfahren in der Leberersatztherapie*

  2003cites this paper
• Artificial liver support system for fulminant hepatic failure as bridge-use to living donor liver transplantation.

  2003cites this paper
• [Acute liver failure].

  2003cites this paper
• New liver support devices in acute liver failure: a critical evaluation.

  2003cites this paper
• Recent advances in liver transplantation.

  2003cites this paper
• New Liver Support Devices in Acute Liver Failure: A Critical Evaluation

  2003cites this paper
• Schwerpunkt: Gastroenterologische Notfälle

  2003cites this paper
• [The bioartificial liver: hopes and realities].

  2002cites this paper
• Bioartificial liver development from a clinical surgeon's perspective: What is necessary for Japan-originated research?

  2002cites this paper
• The Role of Cell-Based Bioartificial Liver Therapy in the Treatment of Fulminant Hepatic Failure

  2002cites this paper
• Medical Aspects of Liver Transplantation

  2002cites this paper
• Bioartificial Liver Support Anno 2001

  2002cites this paper
• Hepatic Stimulator Substance Activity in Animal Model of Fulminant Hepatic Failure and Encephalopathy

  2002cites this paper
• HELLP Syndrome: The Scope of Disease and Treatment

  2002cites this paper
• Entwicklung eines Hepatozytenbioreaktors zur Anwendung in der Toxikologie und Metabolismusforschung: Ein neuartiges in vitro Modell für die online Testung von hepatoaktivierten Substanzen an Indikatorzellen

  2002cites this paper
• Biologic Liver Support: Optimal Cell Source and Mass

  2002cites this paper
• THE VALUE OF HEPATOCYTE TRANSPLANTATION IN THE PROBLEM OF ACUTE LIVER FAILURE IN RATS

  2002cites this paper
• Extracorporeal support of the failing liver

  2002cites this paper
• Extracorporeal liver support by recirculating albumin dialysis: analysing the effect of the first clinically used generation of the MARSystem.

  2002cites this paper
• Function and Dysfunction of the Liver: An Overview

  2001cites this paper
• Current advances in liver support systems.

  2001cites this paper
• Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure.

  2001cites this paper
• Enhancing Filtration Rates by the use of Blood Flow around the Capillaries of Plasmafilters: An in Vitro Study

  2001cites this paper
• Liver transplantation for fulminant hepatic failure

  2001cites this paper
• Activation of hepatic stellate cells in liver tissue of patients with fulminant liver failure after treatment with bioartificial liver.

  2001cites this paper
• Role of Plasmapheresis in the Management of Acute Hepatic Failure in Children

  2001cites this paper
• Derivation of Pharmacokinetics Equations for Quantitative Evaluation of Bioartificial Liver Functions

  2001influential citation
• El esqueleto en la taquilla del hospital

  2001cites this paper